Cited 0 times in 
Cited 0 times in 
Rethinking clinical trial endpoints for evaluating serially delivered ‘strategic radiotherapy’ in oligometastatic or oligoprogressive metastatic disease
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chang, Jeesuk | - |
| dc.contributor.author | Wu, Florence T.H. | - |
| dc.contributor.author | Ko, Heejoo | - |
| dc.contributor.author | Dunne, Emma Maria | - |
| dc.contributor.author | Baker, Sarah | - |
| dc.contributor.author | Liu, Mitchell C. | - |
| dc.date.accessioned | 2026-01-06T00:44:11Z | - |
| dc.date.available | 2026-01-06T00:44:11Z | - |
| dc.date.created | 2026-01-22 | - |
| dc.date.issued | 2025-12 | - |
| dc.identifier.issn | 0304-3835 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/209750 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Elsevier Science Ireland | - |
| dc.relation.isPartOf | Cancer Letters | - |
| dc.relation.isPartOf | CANCER LETTERS | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Rethinking clinical trial endpoints for evaluating serially delivered ‘strategic radiotherapy’ in oligometastatic or oligoprogressive metastatic disease | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Radiation Oncology (방사선종양학교실) | - |
| dc.contributor.googleauthor | Chang, Jeesuk | - |
| dc.contributor.googleauthor | Wu, Florence T.H. | - |
| dc.contributor.googleauthor | Ko, Heejoo | - |
| dc.contributor.googleauthor | Dunne, Emma Maria | - |
| dc.contributor.googleauthor | Baker, Sarah | - |
| dc.contributor.googleauthor | Liu, Mitchell C. | - |
| dc.identifier.doi | 10.1016/j.canlet.2025.218106 | - |
| dc.relation.journalcode | J00448 | - |
| dc.identifier.eissn | 1872-7980 | - |
| dc.identifier.pmid | 41176209 | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0304383525006780 | - |
| dc.contributor.alternativeName | Chang, Jee Suk | - |
| dc.contributor.affiliatedAuthor | Chang, Jeesuk | - |
| dc.contributor.affiliatedAuthor | Ko, Heejoo | - |
| dc.identifier.scopusid | 2-s2.0-105021924083 | - |
| dc.citation.volume | 635 | - |
| dc.identifier.bibliographicCitation | Cancer Letters, Vol.635, 2025-12 | - |
| dc.identifier.rimsid | 91191 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.type.docType | Editorial | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.identifier.articleno | 218106 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.